Posted by Michael Wonder on 06 Sep 2022
Sanofi sees EU regulatory decision on its COVID booster in weeks
5 September 2022 - The European Union's drugs regulator may be a few weeks from deciding whether to approve the experimental COVID-19 vaccine developed by French drug maker Sanofi and its British partner GSK, a Sanofi executive said on Monday.
The companies' bivalent vaccine targets the Beta variant as well as the original Wuhan strain of the virus.
